About Gallant
Gallant is a company based in Los Angeles (United States) founded in 2018 by Davis Brimer and Aaron Hirschhorn. Gallant has raised $61.46 million across 4 funding rounds from investors including Science, Digitalis Ventures and Bold Capital Partners. Gallant offers products and services including Stem Cell Therapies and Clinical Trials. Gallant operates in a competitive market with competitors including eQcell, Bioceltix, Nupsala, J-ARM and Vetherapy, among others.
- Headquarter Los Angeles, United States
- Founders Davis Brimer, Aaron Hirschhorn
- SectorsHealthcare
- Website category Pets and Animals · Pet Food and Supplies
- Email••••••••
- Phone•••• ••••
- Website gallant.com
- Social LinkedIn X Facebook Instagram
- Legal Name Gallant Pet, Inc
- Total Equity Funding$61.46M (USD)
in 4 rounds
- Latest Funding Round$18M (USD), Series B
Jun 2025
- InvestorsScience
& 7 more
Products & Services of Gallant
Gallant offers a comprehensive portfolio of products and services, including Stem Cell Therapies and Clinical Trials.
Uses stem cells to treat pet diseases by reducing inflammation.
Conducts trials for stem cell applications in animal health.
Funding Insights of Gallant
Gallant has successfully raised a total of $61.46M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $18 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $61.46M
- Total Rounds 4
- Last Round Series B — $18M
- First Round $7M
(Aug 2019)
- Investors Count 8
All 4 funding rounds of Gallant with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2025 | $18M | Series B | – | Digitalis Ventures | |
| Dec 2022 | $25.46M | Series A | – | Bold Capital Partners | |
| Oct 2019 | $11M | Series A | – | Maveron, Bling Capital | |
| Aug 2019 | $7M | Series A | – | Bold Capital Partners, Slow Ventures | – |
8 investors in total: 8 institutional.
Investors in Gallant
Gallant has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Science, Digitalis Ventures and Bold Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Digitalis Ventures is engaged in health-focused investments. | – | digitalisventures.com | New York, United States | |
Early-stage life sciences and tech focused VC firm investing primarily in the US | – | boldcapitalpartners.com | Santa Monica, United States | |
Venture capital investments in consumer businesses, emphasizing technology and human behavior. | – | maveron.com | - | |
Seed funding and product council are provided for early-stage companies. | – | blingcap.com | San Francisco, United States | |
Investments are focused on mobile, marketplaces, blockchain, and e-commerce startups. | 2011 | science-inc.com | Santa Monica, United States | |
Early-stage tech investments are made primarily in US companies. | – | slow.co | New York, United States | |
PE firm focused on life science and healthcare companies | – | novaquest.com | Raleigh, United States | |
- | – | hillcreekpartners.tcc.mode | - |
Investor details for Gallant
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Gallant
15 people are tracked at Gallant (8 in leadership, 6 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Davis Brimer | Co-Founder | Leadership |
Aaron Hirschhorn | Co-Founder & CEO | Leadership |
Linda Black | CEO | Leadership |
Valentine Williams, DVM, MS, Diplomate ACVS | Senior Vice President Clinical Development and Regulatory | Leadership |
Mary Climo | Director Of QA | Leadership |
Carolyn Wrightson | CTO | Leadership |
Beau Becker | Senior Director of Operations | Leadership |
Lydia Crystal Cook McAnulty | Director Of Clinical Development | Leadership |
David Haworth Dvm | Advisor | Board & advisors |
Darryl Rawlings | Board Member | Board & advisors |
Richard D. Jennings | Board Member | Board & advisors |
Boaz Arzi | Advisor | Board & advisors |
Dori Borjesson | Advisor | Board & advisors |
Scott R. Burger | Advisor | Board & advisors |
Denise McKay | Operations And Administrative Specialist | Team |
Complete people profiles for Gallant
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Gallant
3 dated milestones of Gallant across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Gallant is founded.
- Funding First funding round of $7.0M.
- Funding Latest funding round, Series B, of $18.0M.
Competitors of Gallant
Gallant operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as eQcell, Bioceltix, Nupsala, J-ARM and Vetherapy, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| eqcell.com | 2010 | Guelph, Canada | $4.6M | 8 | Stem cell therapies for animal health are developed. | |
| bioceltix.com | 2017 | Wroclaw, Poland | – | – | Developer of drugs for veterinary therapy | |
| nupsala.com | 2012 | Melton Mowbray, United Kingdom | $192,595 | 16 | Veterinary pharmaceuticals and products are supplied alongside educational resources. | |
| j-arm.biz | 2006 | Osaka, Japan | – | – | Developer of lymphocyte therapy and stem cell therapy for dogs and cats | |
| vetherapy.co | 2015 | San Francisco, United States | $250,000 | – | Provider of stem cell therapies for pets | |
| vetbiobank.com | 2011 | – | $450,237 | – | Veterinary regenerative medicine | |
| revatis.com | 2013 | Luxemburg, United States | – | – | Undifferentiated muscle-derived stem cells are obtained via patented micro-biopsy technology. | |
| actcells.com | 2008 | San Diego, United States | $10.11M | – | Research and development of veterinary stem cell | |
| theracellinc.com | 2008 | Northridge, United States | $1.42M | – | Allograft solutions for spinal surgery are provided by TheraCell. |
Detailed competitors of Gallant
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Gallant
The website of Gallant (gallant.com) receives about 31K visits a month and ranks #1,301,713 among all websites worldwide, #11,665 in Pet Food and Supplies.
- Monthly visits31K
▲ 38.8% vs previous month
- Unique visitors11.9K
per month
- Global rank#1,301,713
among all websites
- Category rank#11,665
Pets and Animals · Pet Food and Supplies
- Bounce rate55%
- Pages per visit1.5
- Average visit17 sec
- DevicesDesktop 32% · Mobile 68%
Websites whose visitors overlap most with Gallant. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
caringpathways.com | caringpathways.com | 100% | – | #966,632 | – |
dogseechew.in | dogseechew.in | 96% | – | #887,734 | – |
pawsintograce.com | pawsintograce.com | 95% | – | #943,313 | – |
| bark.co | 83% | 1.7M | #27,384 | View details | |
| preventivevet.com | 80% | – | #289,908 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Gallant
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Gallant
Complete news archive for Gallant
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Gallant
10 companies that operate in the same segment as Gallant (Veterinary Digital Health), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Practice and prescription management software is provided for veterinary professionals. | 2010 | Portland, Oregon, United States | USD 291.64 M | – | – | |
Animal medicines, vaccines, and diagnostics are manufactured and supplied. | 2012 | Brussels, Brussels-capital Region, Belgium | – | – | – | |
Veterinary pharmacy services are delivered by VetSource to practices. | 2005 | Portland, Oregon, United States | USD 81.25 M | – | – | |
Animal health therapeutics are developed and supplied globally by Ceva. | 1999 | Libourne, Nouvelle-aquitaine, France | USD 214.35 M | – | – | |
Digital platform for pet insurance | 2020 | Stockholm, Sweden | USD 114.08 M | – | – | |
App based platform providing veterinary services and clinical management solutions for veterinarians | 2018 | Beverly Hills, California, United States | USD 58.81 M | – | – | |
Online client communication platform for veterinary doctors | 2013 | San Diego, California, United States | USD 14.11 M | USD 14.38 M | 1 | |
Virtual veterinary care is provided via an app platform. | 2018 | Los Angeles, California, United States | USD 210 M | – | 163 | |
Comprehensive customer engagement platform for veterinary clinics is provided. | 2015 | Austin, Texas, United States | USD 50.3 M | – | – | |
Veterinary appointments are booked via an online platform. | 2017 | Brooklyn, New York, United States | USD 243 M | – | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Gallant
Gallant was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Gallant is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Aaron Hirschhorn is the current CEO of Gallant. They have also founded this company.
Gallant is a funded company, having raised a total of $61.46M across 4 funding rounds to date. The company's 1st funding round was a Series A of $7M, raised on Aug 2019.
Gallant was founded in 2018 and is based in Los Angeles, United States. The company operates in the veterinary biotechnology sector, focusing on stem cell preservation for dogs. Services include a collection kit provided before spay or neuter procedures, with cells subsequently frozen and stored at the companys facility for future regenerative therapy applications.
Gallant's top competitors include Bioceltix, eQcell and Vetbiobank.
Gallant offers Stem Cell Therapies and Clinical Trials.
Gallant has 8 investors. Key investors include Science, Digitalis Ventures, Bold Capital Partners, Hillcreekpartners, and Maveron.
Gallant operates through Gallant Pet, Inc.